Tapdasa, Meriam .

HRN: 15-57-33  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/07/2026
CEFUROXIME 500MG (TAB)
07/07/2026
07/14/2026
PO
500
Bid
Nsvd With RMLE
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines